Annual Current Assets
$2.00 M
-$567.80 K-22.13%
30 June 2024
Summary:
Renovaro Biosciences annual total current assets is currently $2.00 million, with the most recent change of -$567.80 thousand (-22.13%) on 30 June 2024. During the last 3 years, it has fallen by -$18.90 million (-90.44%). RENB annual current assets is now -90.44% below its all-time high of $20.90 million, reached on 01 June 2021.RENB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$1.95 M
-$49.40 K-2.47%
30 September 2024
Summary:
Renovaro Biosciences quarterly total current assets is currently $1.95 million, with the most recent change of -$49.40 thousand (-2.47%) on 30 September 2024. Over the past year, it has dropped by -$455.00 thousand (-18.93%). RENB quarterly current assets is now -90.68% below its all-time high of $20.90 million, reached on 01 June 2021.RENB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.1% | -18.9% |
| 3 y3 years | -90.4% | -86.7% |
| 5 y5 years | -84.0% | -78.5% |
RENB Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -90.4% | at low | -86.7% | +59.7% |
| 5 y | 5 years | -90.4% | at low | -90.7% | +59.7% |
| alltime | all time | -90.4% | -90.7% |
Renovaro Biosciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.95 M(-2.5%) |
| June 2024 | $161.13 M(+189.1%) | $2.00 M(+63.8%) |
| Mar 2024 | - | $1.22 M(-49.2%) |
| Dec 2023 | - | $2.40 M(+26.1%) |
| Sept 2023 | - | $1.91 M(-25.7%) |
| June 2023 | $55.74 M(-25.8%) | - |
| June 2023 | - | $2.57 M(-34.7%) |
| Mar 2023 | - | $3.93 M(-27.1%) |
| Dec 2022 | - | $5.39 M(-33.7%) |
| Sept 2022 | - | $8.13 M(-15.0%) |
| June 2022 | $75.07 M(-55.5%) | $9.57 M(-18.2%) |
| Mar 2022 | - | $11.70 M(-20.0%) |
| Dec 2021 | - | $14.62 M(-5.4%) |
| Sept 2021 | - | $15.46 M(-26.0%) |
| June 2021 | $168.71 M(-0.3%) | $20.90 M(+324.7%) |
| Mar 2021 | - | $4.92 M(+22.8%) |
| Dec 2020 | - | $4.01 M(-33.9%) |
| Sept 2020 | - | $6.07 M(-32.2%) |
| June 2020 | $169.16 M(+1.1%) | $8.94 M(-20.6%) |
| Mar 2020 | - | $11.27 M(+24.3%) |
| Dec 2019 | - | $9.06 M(-19.1%) |
| Sept 2019 | - | $11.21 M(-10.3%) |
| June 2019 | $167.38 M(+0.4%) | $12.49 M(+18.9%) |
| Mar 2019 | - | $10.51 M(-20.8%) |
| Dec 2018 | - | $13.27 M(-2.1%) |
| Sept 2018 | - | $13.55 M(-14.0%) |
| June 2018 | $166.74 M | $15.76 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $17.07 M(+135.8%) |
| Dec 2017 | - | $7.24 M(+128.9%) |
| Sept 2017 | - | $3.16 M(-24.7%) |
| June 2017 | $323.30 K(+133.6%) | $4.20 M(+1689.0%) |
| Mar 2017 | - | $234.70 K(-16.7%) |
| Dec 2016 | - | $281.60 K(-64.1%) |
| Sept 2016 | - | $784.60 K(+7.1%) |
| June 2016 | $138.40 K(-16.9%) | $732.50 K(-12.3%) |
| Mar 2016 | - | $835.10 K(-30.0%) |
| Dec 2015 | - | $1.19 M(-23.9%) |
| Sept 2015 | - | $1.57 M(-54.9%) |
| June 2015 | $166.60 K(-13.9%) | - |
| Mar 2015 | - | $3.48 M(-31.1%) |
| Dec 2014 | $193.60 K(>+9900.0%) | $5.05 M(+115.2%) |
| Sept 2014 | - | $2.35 M(+454.9%) |
| June 2014 | - | $422.70 K(-24.5%) |
| Mar 2014 | - | $559.80 K(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Sept 2013 | - | $13.20 K(-1.5%) |
| June 2013 | - | $13.40 K(-33.0%) |
| Mar 2013 | $0.00(0.0%) | $20.00 K(+49.3%) |
| Dec 2012 | - | $13.40 K(-13.5%) |
| Sept 2012 | - | $15.50 K(+14.0%) |
| June 2012 | - | $13.60 K(0.0%) |
| Mar 2012 | $0.00(0.0%) | $13.60 K(+2.3%) |
| Dec 2011 | - | $13.30 K |
| Mar 2011 | $0.00 | - |
FAQ
- What is Renovaro Biosciences annual total current assets?
- What is the all time high annual current assets for Renovaro Biosciences?
- What is Renovaro Biosciences annual current assets year-on-year change?
- What is Renovaro Biosciences quarterly total current assets?
- What is the all time high quarterly current assets for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly current assets year-on-year change?
What is Renovaro Biosciences annual total current assets?
The current annual current assets of RENB is $2.00 M
What is the all time high annual current assets for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total current assets is $20.90 M
What is Renovaro Biosciences annual current assets year-on-year change?
Over the past year, RENB annual total current assets has changed by -$567.80 K (-22.13%)
What is Renovaro Biosciences quarterly total current assets?
The current quarterly current assets of RENB is $1.95 M
What is the all time high quarterly current assets for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total current assets is $20.90 M
What is Renovaro Biosciences quarterly current assets year-on-year change?
Over the past year, RENB quarterly total current assets has changed by -$455.00 K (-18.93%)